FDA Warning: RISK OF THYROID C-CELL TUMORS Other GLP-1 agonists been found to cause a dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures in both genders of rats and mice
Due to modern management practices, including winter breeding dates, mares may not be receiving adequate vitamin E nutrition through rations composed solely of hay and grain
Diabetes Obes Metab 18(2):178185 Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
Stress, whether physical, emotional or environmental, can trigger a variety of symptoms in the body
Targeted therapies that leverage cellular-level mechanisms have the potential to significantly improve treatment outcomes for these ulcers, especially in severe cases such as diabetic black foot
This highlights the importance of a multifaceted approach to antioxidant therapy and motivates our exploration of the role of UA in neurodegenerative diseases
